BNP testing performed after triaging patients with acute PE by standard Hestia decision rule is not needed - a randomised trial

Session: Risk stratification in pulmonary embolism and in pulmonary hypertension

Topic: Acute pulmonary embolism

Speaker: Professor M. Huisman (Leiden, NL)

Event: ESC CONGRESS 2015


About the speaker

Professor Menno Huisman

Leiden University Medical Center, Leiden (Netherlands (The))

9 presentations

8 more presentations in this session

Acute pulmonary embolism: external validation of the 2014 risk stratification model of the european society of cardiology

31 August 2015 16:30 - 16:39

Speaker: Doctor C. Becattini (Perugia, IT)


Effectiveness of a clinical score, cardiac troponin, and echocardiography testing algorithm for risk stratification of normotensive patients with acute symptomatic pulmonary embolism

31 August 2015 16:48 - 16:57

Speaker: Professor D. Jimenez (Madrid, ES)


Acute not-high-risk pulmonary embolism: a comparison of risk assessment strategies

31 August 2015 16:57 - 17:06

Speaker: Doctor L. Hobohm (Mainz, DE)


Investigation of a new pathophysiological axis for risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin

31 August 2015 17:06 - 17:15

Speaker: Doctor K. Hellenkamp (Goettingen, DE)


Derivation of a new score to predict chronic thromboembolic pulmonary hypertension after acute pulmonary embolism

31 August 2015 17:15 - 17:24

Speaker: Doctor E. Klok (Leiden, NL)


RV dyssynchrony predicts clinical outcomes after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

31 August 2015 17:24 - 17:33

Speaker: Doctor T. Tsugu (Liege, BE)


Reduction in NT-proBNP and its correlation with survival in patients with PAH treated with riociguat: 2-year results from the PATENT-2 long-term extension study

31 August 2015 17:33 - 17:42

Speaker: Professor M. Hoeper (Hannover, DE)


Outcome comparison of patients with idiopathic/heritable pulmonary arterial hypertension, pulmonary hypertension due to left heart disease and pulmonary hypertension due to lung disease

31 August 2015 17:42 - 17:51

Speaker: Doctor A. Rinaldi (Bologna, IT)